Loeffler endocarditis
Learn about Loeffler endocarditis, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Eosinophilic endocarditis
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis, prevalence. Ask the treating doctor about these.
What it is
From: Orphanet
A rare restrictive cardiomyopathy characterized by hypereosinophilia and fibrous thickening of the endocardium, with usually large thrombi against the ventricle walls, that can lead to cardiovascular complications such as heart failure and thromboembolism. It manifests with symptoms like edema, fatigue and shortness of breath. It is usually secondary to eosinophil-associated tissue damage and is associated with idiopathic hypereosinophilic syndrome, chronic eosinophilic leukemia, carcinoma, or lymphoma.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal thrombosis · Very frequent (99-80%)
- Venous or arterial thrombosis (formation of blood clots) of spontaneous nature and which cannot be fully explained by acquired risk (e.g. atherosclerosis).
- Increased total eosinophil count · Very frequent (99-80%)
- Increased count of eosinophils in the blood.
- Myocardial eosinophilic infiltration · Very frequent (99-80%)
- An increase in the number of eosinophils in myocardial tissue.
- Restrictive cardiomyopathy · Very frequent (99-80%)
- Restrictive left ventricular physiology is characterized by a pattern of ventricular filling in which increased stiffness of the myocardium causes ventricular pressure to rise precipitously with only small increases in volume, defined as restrictive ventricular physiology in the presence of normal or reduced diastolic volumes (of one or both ventricles), normal or reduced systolic volumes, and normal ventricular wall thickness.
- Abnormal cardiomyocyte morphology · Frequent (79-30%)
- Any structural anomaly of cardiomyocytes, which are terminally differentiated muscle cells in the heart that are interconnected end to end by gap junctions, which allows coordinated contraction of heart tissue.
- Abnormal heart valve morphology · Frequent (79-30%)
- Any structural abnormality of a cardiac valve.
- Chest pain · Frequent (79-30%)
- An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the chest.
- Congestive heart failure · Frequent (79-30%)
- The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction.
- Dyspnea · Frequent (79-30%)
- Difficult or labored breathing. Dyspnea is a subjective feeling only the patient can rate, e.g., on a Borg scale.
- Fatigue · Frequent (79-30%)
- A subjective feeling of tiredness characterized by a lack of energy and motivation.
- Left ventricular diastolic dysfunction · Frequent (79-30%)
- Abnormal function of the left ventricule during left ventricular relaxation and filling.
- Left ventricular hypertrophy · Frequent (79-30%)
- Enlargement or increased size of the heart left ventricle.
- Palpitations · Frequent (79-30%)
- A sensation that the heart is pounding or racing, which is a non-specific sign but may be a manifestation of arrhythmia.
- Weight loss · Frequent (79-30%)
- Reduction of total body weight.
Other findings in the same source
From: Orphanet
Additional reported features include Abnormal morphology of the chordae tendinae of the mitral valve (Occasional (29-5%)); Abnormal tricuspid chordae tendinae morphology (Occasional (29-5%)); Arrhythmia (Occasional (29-5%)); Cough (Occasional (29-5%)); Endocardial fibrosis (Occasional (29-5%)); Left atrial enlargement (Occasional (29-5%)); Mitral regurgitation (Occasional (29-5%)); Myocardial fibrosis (Occasional (29-5%)); Right bundle branch block (Occasional (29-5%)); T-wave inversion (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Adolescent; Adult; Childhood
Which doctor should you see?
The suggested department for discussing Loeffler endocarditis is Cardiology, with a cardiologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Is the main concern heart structure, rhythm, circulation or another cause?
- Which symptoms should change the timing of follow-up?
- How would a proposed investigation change the care plan?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Loeffler endocarditis. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by a cardiologist. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Loeffler endocarditis — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1439.